10/28/2024
4:23 PM | Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
7:27 AM | Elite Pharmaceuticals (Subject)
Plassche Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:47 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:16 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
4:21 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
4:26 PM | Elite Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/20/2024
3:30 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:56 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4/A | |
04/02/2024
3:58 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:06 PM | Elite Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:06 PM | Elite Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
3:55 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
1:21 PM | Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
5:58 PM | Caskey Davis S (Reporting)
Elite Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
6:05 PM | Elite Pharmaceuticals (Issuer)
WHITNELL JEFFREY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:50 PM | Dash Barry H (Reporting)
Elite Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
